Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors

BACKGROUND: Headache is one of the most frequently reported symptoms in post-COVID patients. The clinical phenotype of COVID-19 headache combines phenotypic features of both tension-type headache (TTH) and migraine. We aimed to assess the effectiveness, side effects and predictors of amitriptyline (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Martinez, Alicia, Guerrero-Peral, Ángel Luis, Arias-Rivas, Susana, Silva, Lorenzo, Sierra, Álvaro, Gago-Veiga, Ana Beatriz, García-Azorín, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553757/
https://www.ncbi.nlm.nih.gov/pubmed/35829760
http://dx.doi.org/10.1007/s00415-022-11225-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553757/
https://www.ncbi.nlm.nih.gov/pubmed/35829760
http://dx.doi.org/10.1007/s00415-022-11225-5

Ejemplares similares